
Taiji Group
Taiji Group (Guoyao Taiji) is a China National Pharmaceutical Group member enterprise focused on modern TCM intelligent manufacturing with specialty chemical drugs as a supplement.
Last updated November 4, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Taiji Group Co., Ltd. ("Guoyao Taiji") is a member enterprise of China National Pharmaceutical Group Corporation ("Sinopharm"). Its predecessor was the Sichuan Fuling Traditional Chinese Medicine Factory founded in 1972; it was listed on the Shanghai Stock Exchange in 1997 (ticker 600129.SH) and became a Sinopharm-controlled subsidiary through strategic restructuring in 2021. Guoyao Taiji focuses on modern TCM intelligent manufacturing with specialty narcotic/psychotropic chemical drugs as a supplement, and its business covers pharmaceutical R&D, pharmaceutical industry, pharmaceutical commerce, Chinese medicinal material resources, and international health industry. It holds 1,240 drug approval numbers and has more than 10,000 employees. Its brand value proposition is "正源出新" and it positions itself as "traditional TCM inheritor + modern TCM innovator + TCM ecosystem builder."
History
The predecessor of Taiji Group Co., Ltd. was the Sichuan Fuling Traditional Chinese Medicine Factory founded in 1972. It was listed on the Shanghai Stock Exchange in 1997 (ticker 600129.SH). In 2021, through strategic restructuring, it became a Sinopharm-controlled subsidiary. Its development history page lists dates including 1752, 1851, 1908, 1928, 1950, 1972, 1987, 1988, 1992, 1993, 1995, 1996, 1997, 1998, 2003, 2016, 2021, and 2026, with the earliest entry noting the founding of the "震元堂" medicine processing workshop (predecessor of the former Shaoxing Traditional Chinese Medicine Factory and Taiji Group Zhejiang Dongfang Pharmaceutical Co., Ltd.).
- 2021
Through strategic restructuring, became a controlled subsidiary of China National Pharmaceutical Group (Sinopharm).
- 1997
Listed on the Shanghai Stock Exchange (stock code 600129.SH).
- 1972
Sichuan Fuling Traditional Chinese Medicine Factory founded, the direct predecessor of Taiji Group.
- 1908
Tongjun Pavilion prepared medicine shop founded by Xu Jian'an (predecessor of Taiji Group Chongqing Tongjun Pavilion Pharmaceutical Factory Co., Ltd.).
- 1851
Xiangshun Tang pharmacy founded (predecessor of Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd., formerly Sichuan Mianyang Pharmaceutical Factory).
- 1752
Zhenyuan Tang medicine processing workshop founded (predecessor of Taiji Group Zhejiang Dongfang Pharmaceutical Co., Ltd., formerly Shaoxing Traditional Chinese Medicine Factory).
Products and positioning
Inheritor of traditional Chinese medicine, innovator in modern Chinese medicine, and builder of a Chinese medicine ecosystem
太极藿香正气口服液
Relieves exterior symptoms and resolves dampness; regulates qi and harmonizes the middle
太极急支糖浆
Clears heat and resolves phlegm; diffuses the lung and stops cough
太极通天口服液
Invigorates blood and dispels stasis; dispels wind and relieves pain
太极上草
Good provenance, good ecology, zero exceedances of heavy metals
Controversies
2022
Huoxiang Zhengqi Water flagged by NMPA over excessive methanol
In August 2022, the National Medical Products Administration notified 20 batches of drugs as noncompliant, including three batches of Huoxiang Zhengqi Water from Taiji Group subsidiary Nanchong Pharmaceutical with methanol levels exceeding the limit. Taiji Group apologized and recalled 15,677 boxes from the unsold portion; drug regulators required a case investigation.
2017
Taiji Group's Chongqing TCM No.2 Factory penalized over substandard Xiao'er Kechuanling Granules
CNR disclosed the Chongqing Food and Drug Administration's fourth enforcement information for 2016: batch 1401003 of Xiao'er Kechuanling Granules produced by Chongqing Traditional Chinese Medicine No.2 Factory had properties that did not meet specifications, was deemed an inferior drug, and illegal gains were confiscated. The incident was limited to the notified batch. Progress: media reported the regulatory enforcement result. Subject: Taiji Group Chongqing Traditional Chinese Medicine No.2 Factory Co., Ltd. Scope: products and administrative enforcement events of its Taiji Group Chongqing Traditional Chinese Medicine No.2 Factory.
Recent events
Sources9 sources
- 1太极集团主页taiji.com
- 2发展历程_太极集团taiji.com
- 3公司概况_太极集团taiji.com
- 4百年企业_太极集团taiji.com
- 5Taiji Group's Chongqing TCM No.2 Factory penalized over substandard Xiao'er Kechuanling Granulesnews.cnr.cn
- 6Huoxiang Zhengqi Water flagged by NMPA over excessive methanolthepaper.cn
- 7Huoxiang Zhengqi Water flagged by NMPA over excessive methanolchinanews.com.cn
- 8Huoxiang Zhengqi Water flagged by NMPA over excessive methanolepaper.zqrb.cn
- 9铭瑄联合长鑫存储发布太极 G3 DDR4 内存diy.it168.com
Cite this profile: Cite the canonical profile. /brand-wiki/太极集团 · Editorial policy · How profiles are compiled